Search Results for:

Ohio University Innovation Center July 2020 newsletter

READ MORE
July 2, 2020 | Ohio University

Case Western Reserve University-led team develops new approach to treat certain neurological diseases

READ MORE
July 2, 2020 | The Daily at CWRU

NAMSA & RAPS present Achieving Medical Device Development Success Through Early Implementation of Regulatory, Reimbursement and Clinical Research Strategies

Regulatory affairs professionals must have both a solid foundation surrounding regulatory strategy and an in-depth understanding of how this plan links to the overall product development strategy to achieve efficient, cost-effective development outcomes, and commercialization success. Whether navigating a new regulatory pathway, understanding how to secure clinical data to achieve successful commercial outcomes or ensuring […]

READ MORE
July 2, 2020

Omnia Health Live Americas

As we try to continue business as usual across the medical device and healthcare industry, while keeping our colleagues and families safe during the global coronavirus pandemic, we are proud to bring you an innovative alternative to the traditional in-person trade show and conference experience. Introducing Omnia Health Live Americas The teams behind Expo Med […]

READ MORE
July 2, 2020

Myriad launches new GeneSight Psychotropic Patient Collection Kit

READ MORE
July 1, 2020 | Myriad

Pfizer and BioNTech announce early positive data from an ongoing Phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2

READ MORE
July 1, 2020 | Pfizer

Kroger Health receives FDA Emergency Use Authorization for its COVID-19 test home collection kit

READ MORE
July 1, 2020 | Kroger

NASA and University Hospitals join forces to develop new methods and technologies for decontaminating personal protective equipment

READ MORE
June 30, 2020 | NASA Glenn Research Center

Scientist I/II at Haima Therapeutics LLC

Haima Therapeutics is a pre-clinical stage biotechnology company located in Cleveland, OH focused on developing platelet-inspired therapies to provide therapy for multiple indications including hemorrhage, inflammation, thrombosis, and cancer. Our lead product, is a synthetic intravenous hemostatic technology, called SynthoPlate, that can staunch bleeding by amplifying your body’s natural clotting mechanisms. Haima is seeking to […]

READ MORE
June 29, 2020

S4 Medical Corp receives IDE approval from the FDA

READ MORE
June 29, 2020 | EIN Presswire